首发未用药精神分裂症患者攻击行为与血清C反应蛋白的相关性
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

山东省医药卫生科技发展计划(202003090933)


Correlation between serum C-reactive protein level and aggressive behavior in first episode drug naive schizophrenia patients
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨首发未用药精神分裂症患者血清 C 反应蛋白(CRP)水平及临床症状对攻击行 为的影响。方法 选取2020年1月至2022年11月在山东省精神卫生中心门诊就诊或者住院治疗的164例 首发未用药精神分裂症患者为研究对象。采用修改版外显攻击行为量表(MOAS)评估患者的攻击行 为,根据 MOAS 结果将患者分为攻击组(86 例)和非攻击组(78 例)。采用阳性与阴性症状量表(PANSS) 评定患者的临床症状。采用二项 Logistic 分层回归分析首发未用药精神分裂症患者有攻击行为的影响 因素。结果 攻击组患者的血清 CRP 水平[2.97(2.46,3.47)mg/L 比 1.73(1.36,2.10)mg/L]、PANSS 总分 [(89.27±9.82)分比(83.47±8.04)分]、阳性症状因子评分[33.90(33.01,34.79)分比30.13(29.28,30.98)分]、 兴奋激越因子评分[14.12(13.43,14.80)分比 7.01(6.41,7.61)分]、MOAS 总分[12.85(11.90,13.80)分比 2.28(1.36,3.20)分]、言语攻击维度评分[1.28(1.15,1.41)分比 0.38(0.27,0.50)分]、财产攻击维度评分 [1.47(1.32,1.61)分比 0.28(0.15,0.41)分]及体力攻击维度评分[2.01(1.85,2.17)分比 0.14(0.01,0.27)分] 均高于非攻击组,差异均有统计学意义(均P<0.01)。攻击组的阴性症状因子评分[24.63(23.64,25.62)分 比28.15(26.90,29.40)分]和认知缺损因子评分[10.76(10.24,11.27)分比 11.60(10.98,12.23)分]低于非 攻击组,差异有统计学意义(均P< 0.05)。二项 Logistic 分层回归分析结果显示,病程长是首发未用药精 神分裂症患者有攻击行为的独立保护因素(均P< 0.01),PANSS 中的兴奋激越因子评分高、血清 CRP 水 平高是首发未用药精神分裂症患者有攻击行为的独立危险因素(均P< 0.05)。结论 血清 CRP 水平高、 兴奋激越因子评分高是首发未用药精神分裂症患者实施攻击行为的危险因素,有攻击行为患者的病程 短于非攻击行为患者,可能与攻击行为更能引起人们的重视相关 。

    Abstract:

    Objective To investigate the effects of serum C-reactive protein (CRP) level and clinical symptoms on aggressive behavior in untreated first-episode schizophrenia patients. Methods A total of 164 untreated patients with first-episode schizophrenia in the department of outpatient and inpatient of Shandong Mental Health Center from January 2020 to November 2022 were selected as research subjects. The modified Overt Aggression Scale (MOAS) were applied to assess patients aggressive behavior. According to the results of MOAS, the patients were divided into the aggressive group (86 cases) and the non-aggressive group (78 cases). The Positive and Negative Symptom Scale (PANSS) was used to evaluate the clinical symptoms of the patients. Binomial Logistic hierarchical regression analysis was used to analyze the influencing factors of aggressive behavior in untreated first-episode schizophrenia patients. Results The serum CPR level [2.97 (2.46,3.47)mg/L vs 1.73 (1.36,2.10) mg/L], total scores of PANSS [(89.27±9.82) vs (83.47±8.04)], positive factor scores [33.90 (33.01, 34.79) vs 30.13 (29.28, 30.98)], excitement factor scores [14.12 (13.43, 14.80) vs 7.01 (6.41, 7.61)], total scores of MOA [12.85 (11.90,13.80) vs 2.28 (1.36, 3.20)], verbal aggression scores [1.28(1.15, 1.41) vs 0.38 (0.27, 0.50)], aggression against property scores [1.47 (1.32,1.61) vs 0.28 (0.15,0.41)] and physical aggression scores [2.01 (1.85, 2.17) vs 0.14 (0.01,0.27)] of the aggressive group were all higher than those of the non-aggressive group, and the differences were statistically significant (P < 0.01). The negative factor scores [24.63(23.64, 25.62) vs 28.15 (26.90, 29.40)] and cognitive factor scores [10.76 (10.24, 11.27) vs 11.60 (10.98, 12.23)] of the aggressive group were lower than those of the non-aggressive group (P < 0.05). The results of binomial Logistic hierarchical regression analysis showed that long duration of disease was the independent protective factor of aggressive behavior in untreated first-episode schizophrenia patients (P< 0.05). High score of excitement factor of PANSS and high serum CRP level were independent risk factors of aggressive behavior in untreated first-episode schizophrenia patients (P< 0.05). Conclusions High score of excitement factor of PANSS and high serum CRP level are independent risk factors of aggressive behavior in untreated firstepisode schizophrenia patients. Patients with aggressive behavior have a shorter course of disease than patients without aggressive behavior, which may be due to the fact that aggressive behavior attracts more attention.

    参考文献
    相似文献
    引证文献
引用本文

张仁云,张真真,范允明,崔开艳,李翠鸾.首发未用药精神分裂症患者攻击行为与血清C反应蛋白的相关性[J].神经疾病与精神卫生,2023,23(3):
DOI :10.3969/j. issn.1009-6574.2023.03.002.

复制
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-05-06